Emergent Biosolutions, Inc. News Headlines

EBS 
$22.81
*  
0.13
0.57%
Get EBS Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading EBS now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Amazon Offers Low-End EC2 Instances (revised) - Analyst Blog
7/7/2014 1:15:58 PM - Zacks.com

Amazon Offers Low-end EC2 Instances - Analyst Blog
7/2/2014 6:05:00 PM - Zacks.com

Moody's: Hungary Court Ruling on FX Loans Credit Could Hurt Banks
6/23/2014 6:38:00 AM - Dow Jones Business News

Emergent BioSolutions To Present At Jefferies Conference; Webcast At 1:00 PM ET
6/5/2014 12:01:00 PM - RTT News

Emergent BioSolutions To Present At UBS Global Conference; Webcast At 4:00 PM
5/19/2014 3:00:00 PM - RTT News

Biodel Q2 Loss Wider Than Expected - Analyst Blog
5/16/2014 10:20:00 AM - Zacks.com

Emergent BioSolutions BoA Merrill Lynch Conference ; Webcast At 6:40 PM ET
5/13/2014 3:00:00 PM - RTT News

Healthcare Stocks Adding to Day-Long Surge; Emergent BioSolutions Slumps After Street.com Downgrade
5/12/2014 3:58:05 PM - MT Newswires

Sector Update: Healthcare
5/12/2014 3:55:22 PM - MT Newswires

Shares Continue to fall on Emergent BioSolutions' Wider Loss - Analyst Blog
5/12/2014 10:10:00 AM - Zacks.com

Healthcare Stocks Nudging Back into the Green; Emergent BioSciences Declines After Q1 Miss, Weak Q2 Outlook
5/9/2014 3:39:38 PM - MT Newswires

Sector Update: Healthcare
5/9/2014 3:38:57 PM - MT Newswires

J&J /Gilead HCV Combo Drug Filed - Analyst Blog
5/8/2014 4:55:00 PM - Zacks.com

Emergent's BioThrax Gets Orphan Drug Status - Analyst Blog
4/24/2014 7:10:01 PM - Zacks.com

Biodel, HEC Pharm Ink Deal - Analyst Blog
4/24/2014 5:30:01 PM - Zacks.com

Emergent BioSolutions Gains on Trial News - Analyst Blog
4/17/2014 5:10:01 PM - Zacks.com

Emergent BioSolutions Is Building An Enviable BioDefense Portfolio
3/17/2014 12:18:08 PM - SeekingAlpha

Emergent BioSolutions Is Building An Enviable BioDefense Portfolio
3/17/2014 12:18:00 PM - Seeking Alpha

Don't Disregard These 3 Biotech Plays In 2014
3/10/2014 3:27:00 PM - Seeking Alpha

Emergent Beats on Earnings & Revenues, Shares Up - Analyst Blog
3/10/2014 9:10:01 AM - Zacks.com

Why You Need to Pay Attention to Kamada (KMDA) Stock? - Tale of the Tape
3/7/2014 10:00:01 AM - Zacks.com

Celldex Posts Narrower-Than-Expected Loss in Q4 - Analyst Blog
3/4/2014 12:30:01 PM - Zacks.com

Celldex Therapeutics (CLDX) in Focus: Stock Tumbles 10.1% - Tale of the Tape
3/4/2014 9:56:01 AM - Zacks.com

Dendreon Corp. (DNDN) Soars: Stock Rises 14.9% - Tale of the Tape
3/4/2014 9:51:01 AM - Zacks.com

EU Review for The Medicines Co.'s Oritavancin - Analyst Blog
3/3/2014 6:55:01 PM - Zacks.com